|
- Novartis | Cafepharma Message Boards | Pharma Sales, Device Sales, Lab . . .
What's your favorite blunder at Novartis in the last 10 years? Anonymous; Jul 7, 2010; 4 5 6 Replies 103
- Novartis closes technical R D site in San Diego as part of ongoing . . .
An R D center in San Diego is the latest area to be impacted by Novartis’ ongoing global development restructure, the company has confirmed The Swiss Big Pharma will conduct a “phased exit” from the Technical Research and Development (TRD) site at Campus Point Drive, with “final closure anticipated by end of 2025,” the company
- Pharma Biotech Companies | Cafepharma Message Boards | Pharma Sales . . .
Anonymous discussion boards for pharmaceutical and biotech companies
- Medical Equipment Device Sales - Cafepharma
Anonymous discussion boards for medical equipment device companies
- News Feed - Cafepharma
Swiss drugmaker Novartis (SIX:NOVN) will pay up to $1 billion to U S biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases Matchpoint said on Thursday it will use its technology to develop drugs that block the activity of a specific protein, helping to lower the production of inflammation-causing signals
- Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban Novo Nordisk board Roche’s Alzheimer’s therapy shows continued benefit
- Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical device sales, lab diagnostics sales
- The 5 largest biopharma layoffs of Q1 2025 | Cafepharma
Layoffs pushed thousands of pharma and biotech professionals into the job market in the first quarter, albeit at a slower pace than last year
|
|
|